WTI was awarded a prime position on the DHA OMNIBUS IV Military Medical Research and Development Contract. This is an indefinite delivery/indefinite quantity (IDIQ), multiple-award contract with a ceiling value of $10 billion.

The Department of Defense has an on-going need for discovery and integration of innovative medical knowledge and material solutions to continually enhance Force health readiness, resilience and rehabilitation. OMNIBUS IV is designed to enhance the related medical research and development programs of the Department of Defense.

The OMNIBUS IV requirement provides for a broad range of health-related research and development and support services that are separated into four Market Segments:

  1. Research and Development (R&D)
  2. R&D Support Services
  3. Regulatory Processes
  4. Translational Science Support and Services

For more information, email [email protected].